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Abstract
Prosthetic prescription for lower limb
amputees and the methodology used are
primarily based on empirical knowledge.
Clinical expertise plays an important role that
can lead to an adequate prescription; however, a
clear evidence based motivation for the choices
made cannot be given. This can lead to local
prescription variations with regard to overuse or
underuse of prosthetic care and a lack of
transparency for consumers and health insurance
companies. Hence a clinical guideline may lead
to a more consistent and efficient clinical
practice and thus more uniformly high quality
care.
The purpose of this study was to get insight
into potential similarities in prescription criteria
in clinical practice in the Netherlands. Secondly,
the authors were interested to know if prosthetic
prescription was primarily based on the level of
activity or intended use of the prosthesis.
As part of the development of a consensus-
based clinical guideline a multi-centred, cross-
sectional study was carried out in order to
observe the prosthetic prescription for a group of
lower limb amputees. Therefore prescription
data were collected from 151 amputees with
trans-femoral amputation, knee disarticulation
or trans-tibial amputation.
Results of the multiple logistic regression
show no relationship between the activity level
and any of the variables included in the equation
such as the hospital or medical doctor in
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Physical and Rehabilitation Medicine (MD in
P&RM), prosthetic components, age of the
amputee or reason of amputation. The criteria
used are merely based on the clinical expertise
and local experience whereas the actual
prescriptions differ from location to location.
In conclusion the development of a clinical
guideline for prosthetic prescription in lower
limb amputation is recommended. The
information gained from this observational study
will be used in a clinical guideline procedure for
prosthetic prescription in the Netherlands.
Introduction
In the Netherlands the incidence of major
lower limb amputation is about 19 per 100,000
habitants (CBS, 1999). These include
amputations from the trans-metatarsal to the
trans-pelvic level. For an amputee population in
the north of the Netherlands in 1991 and 1992
(Rommers et al., 1996) approximately 82% of
the total lower limb amputations occurred as a
result of vascular diseases, 9% were traumatic
amputations and 9% were the result of
oncological conditions. Stewart and Jain (1993)
found similar figures in Scotland. In the
Netherlands, 86% of all lower limb amputations
are trans-femoral (TF) (34%)," knee
disarticulation (KD) (10%) or trans-tibial (TT)
(42%) (CBS, 1999). Of these amputees, 48%
were fitted with a prosthesis (Rommers et al,
1997).
In the Netherlands a prosthesis is prescribed in
clinical practice by a medical doctor in Physical
and Rehabilitation Medicine (MD in P&RM) in
collaboration with a prosthetist and sometimes
with the advice of a physical therapist. This


































rehabilitation centres or general hospitals. The
role of the MD in P&RM and the prosthetist as
members of a clinical team is slightly different
from that in other industrialised countries. The MD
in P&RM is not only responsible for information
on medical aspects but also has a leading role in
choosing the prosthetic components. In addition,
the training level of the prosthetists has been of a
lower category up to now.
In the Netherlands, and probably everywhere
else in the world, prosthetic prescription for
lower limb amputees and the used methodology
are primarily based on empirical knowledge.
This knowledge is transmitted to professionals
by "residents' clinical training" and is further
developed and renewed in clinical practice and
by courses and symposia. These developments
and renewals have not been established in a
standardised way, i.e. there is no existing
clinical guideline. Experience plays an
important role that can lead to an adequate
prescription; however, a clear evidence-based
motivation for the choices made cannot always
be given. This can lead to local prescription
variations as to overuse or underuse of prosthetic
care and a lack of transparency for consumers
and health insurance companies. Hence a
clinical guideline can lead to a more consistent
and efficient clinical practice and more
uniformly high quality care (Trickey et al,
1998; Woolf et al, 1999).
Multiple factors must be considered in the
prosthetic prescription for an individual
amputee. The amputee's general health (co-
morbidity), mental state, living circumstances
and vocational interests must be considered in
addition to the level of amputation (Bowker,
1992; Rubin et al, 1996). There is a growing
awareness that the prescription has to match the
intended use of a prosthesis (Menard et al,
1992; Cortes et al, 1997).
Classification of amputees based on
functional abilities can be of use in
differentiating among the different levels of
prosthetic prescription (Gailey et al., 2002). In
general terms a prosthetic prescription should
be based on matching the functional needs of
the amputee with the functional capacities of
the prosthetic device (Cortes et al., 1997). In
the authors' view an adequate instrument in the
classification of amputees for prosthetic
prescription is not available. The Special
Interest Group for Amputee Medicine
(SIGAM) of the British Society of
Rehabilitation Medicine (BSRM) uses a
validated scale of "disability mobility grades"
in prosthetic prescription (Stewart, 2001).
Several questionnaires on prosthetic use,
functional aspects of a prosthesis and general
activities are available too. However, none of
these offer explicit information on how to
translate the amputee's functional ability into
an adequate prosthetic prescription (Alaranta et
al, 1994; Gauthier-Gagnon et al, 1998;
MacFarlane et al, 1997). A mobility scale can
be a good starting point. However, Rommers et
al. (2001) found that the existing mobility
instruments for lower limb amputees differ
considerably and only measure certain aspects
of mobility. In the authors' opinion for this
study the 5-level functional classification used
by the US Health Care Financing
Administration (HCFA) is most suitable
(HCFA, 2001). Based on this classification
Gailey et al. (2002) developed "The Amputee
Mobility Predictor" as a valid instrument to
measure the ability to ambulate with a
prosthesis. However, prosthetic prescription
needs additional research.
There are some difficulties in using the results
from studies on biomechanical aspects and
functional characteristics of several prosthetic
components for prescription criteria. Outcome
measures differ from study to study, therefore
comparison or meta-analysis of the results is
difficult. However, the explicit knowledge
derived from literature is needed to develop a
clinical guideline (Woolf et al, 1999). In cases
where literature findings are not appropriate or
subject areas have not been researched,
development of a clinical guideline has to rely
on other sources of evidence. Accordingly,
professionals can provide expert opinion and in
addition knowledge from clinical experience
(Rycroft-Malone, 2001).
As part of the development of a consensus-
based clinical guideline the authors gathered
implicit information on prosthetic prescription in
the Netherlands by using an observational study
of prescription in clinical practice and an
interview with leading experts in the field of
prosthetics.
The purpose of this study was to get insight
into possible similarities in prescription criteria
in practice. Secondly, it was of interest to
discover if prosthetic prescription was primarily
based on the amputee's level of activity or the
































172 H. Van der Linde, J. H. B. Geertzen, C. J. Hofstad, J. van Limbeek and K. Postema
The results will be used in the guideline-
developing consensus procedure carried out in
the Netherlands concerning the prescription for
prostheses of the lower limb.
Methodology
Subjects
In the present study a multi-centred, cross-
sectional study was carried out in order to
observe the prosthetic prescription of a group of
lower limb amputees. To collect these data, 16
hospitals were selected. A hospital was included
if sufficient and adequate expertise on
amputation and prosthetics was present in the
rehabilitation team that provided the prosthesis.
The MD in P&RM within those teams were all
members of a professional working-group of
physicians in P&RM focused on amputation and
prosthetics in the Netherlands. Secondly the
amount of prosthetic prescriptions in the
selected hospitals had to exceed 100
prescriptions on an annual basis. The selected
hospitals were evenly distributed across the
Netherlands.
Data were collected from inpatient and
outpatient amputees with a TF amputation, KD
or TT amputation. Patients with primary as well
as secondary amputations were included. There
were no restrictions concerning age, gender or
race of the amputees, on the side and date of the
amputation or the reason for amputation.
Since no valid assessment instrument was
available, an assessment form was developed on
which data of patient, hospital and prosthesis
could be recorded in a standardised way.
For classification of the amputee's level of
activity the coding system of the HCFA seemed
the most appropriate (HCFA, 2001):
• if an amputee has the ability or potential to
use a prosthesis for transfers or ambulation
on level surfaces at fixed cadence, he or she
is assessed as Kl. This can be typified as a
limited and unlimited household ambulator;
• a K2-amputee has the ability or potential for
ambulation with the ability to traverse low
level environmental barriers such as kerbs,
stairs or uneven surfaces. This is typical for
the limited community ambulator;
• a more active amputee with the ability or
potential for ambulation with variable
cadence is assessed as K3. This is a
community ambulator who has the ability to
traverse most obstacles and may have
vocational, therapeutic or exercise activities
that demand prosthetic utilisation beyond
simple locomotion;
• most active amputees are graded as K4 and
have the ability or potential for prosthetic
ambulation that exceeds basic ambulation
skills, exhibiting high impact, stress, or
energy levels. This is typical for the
prosthetic demands of a child, an active adult
or an athlete.
The observations were performed by two
researchers (HL and CH). The observed
decisions or remarks were extended with
questions to rehabilitation-team members or
amputees when items on the structured
observation list were not mentioned. The
activity level resulted from the appraisal of both
the remarks of the team members and the
amputees on this subject.
Analysis
To facilitate the analyses, level of activity was
assessed as a dichotomous variable. Therefore
the amputees were classified into two levels of
activity. Activity level 1 included Kl and K2-
amputees, whereas activity level 2 included the
K3 and K4-amputees.
The Netherlands was divided into three areas:
the northern and eastern parts including 7
hospitals, the western part with 6 hospitals, and
the southern area with 3 hospitals. Other
variables were age, sex, level of amputation,
reason for amputation, date of amputation,
primary or secondary prosthesis and co-
morbidity. Codes of these variables are given in
Figure 1. Prosthetic prescription variables were
coded in the categories: socket, weight-bearing
and suspension principle, knee- and ankle-foot
mechanism.
Data were processed using SPSS version 9.0
and Egret. The statistical procedures used were
Spearman correlations and Multiple Logistic
Regressions. The logistic regression analysis
was performed on the binary variable activity
level to find relationships between activity level
and prosthetic prescription, patient data and data
of the hospitals visited.
Results
The studied population consisted of 151
amputees, including 3 bilateral ones, of whom
both prostheses were separately recorded in the























































111 I 100%80%g 60%





Fig. 1. Amputees' demographics: 'Total' = total database (n=151), " IT = database trans-tibial amputees (n=94),
'KD' = database knee disarticulation amputees (n=16), 'TF' = database trans-fermoral amputees (n=41).
prescriptions for major lower limb amputations
was observed during 25 visits to 16 hospitals in
the Netherlands. For 1 amputee the assessment
form was incomplete and therefore it was left
out of the databases. For 2 amputees it was
impossible to assess their activity level, because
these patients were amputated for complex
regional pain syndrome type I (CRPS I) and the
patient as well as the MD in P&RM were
uncertain about the future activities of the
amputee. These 3 amputees were left out of the
database, in all, the total database included 151
prescriptions of whom 94 cases were TT
amputees (62%), 41 TF cases (27%) and only 16
cases (11%) were KD amputees.
The majority of the studied population was 70
years or older (37%), the group of 55-70 year
olds was somewhat smaller (35%) (Fig. 1).
Seventy per cent (70%) was male and 75% of
the studied population was graded into the group
with activity level 1. In 36% of the cases
amputation was performed because of vascular
reasons (with or without diabetes mellitus), in
27% and 29% respectively amputation had been
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Without knee lock 13 (100)

































































































































Act 1: amputees with activity level (Kl or K2). Act 2: amputees with activity level 2 (K3 or K4). In the tables the absolute

































Most amputations had been performed more than
2 years before this study. In 57% of the total
cases it concerned primary amputations. One
hundred and twenty-seven (127) cases (84%)
were free from medical limitations/restrictions,
while 16 cases (11%) had physical restrictions
such as cardiac diseases and 8 cases (5%)
suffered from limitations due to rheumatoid
arthritis or stroke.
Seventy-eight (78) (51%) of the amputees
received their prostheses in the western part of
the Netherlands, while 31% went to hospitals in
the northern and eastern part of the country.
Fifty percent (50%) of the MDs in P&MR were
trained in the north and east of the Netherlands,
48% in the western part. The professional
experience of the MDs in P&MR in the field of
amputation and prosthetics did not seem to
influence the prosthetic prescriptions.
The results of the observations on the
prosthetic prescription for all 151 cases are
shown in Table 1. Prosthetic prescription is split
up for the three amputation levels and the
activity level. Four different ankle-foot
mechanisms were distinguished (solid-ankle,
single-axis, energy-storing, multi-flexible). The
solid-ankle foot is prescribed primarily for TT
amputees with a lower activity level (49%). The
energy-strong feet are prescribed more often in
the prescriptions for TT amputees with a higher
activity level (30% vs. 8%). However, the 4
identified ankle-foot mechanisms are evenly
distributed for this activity level. For KD and TF
amputees the choice for the prosthetic foot is not
clearly related to the level of activity either.
Two aspects of the prosthetic socket were
distinguished: the suspension and weight
bearing principles. The authors noticed a
distribution over the various principles for the 3
amputation levels, without a clear relationship to
the level of activity. Single-axis or four-axes
knee-mechanisms are prescribed merely for
lower-activity TF amputees with a 31% knee
lock in this group.
Results of the multiple logistic regression only
showed a relation between the age of the
amputee and the level of activity (p<0.001, SE
0.27, coefficient -1.18). There were no relations
between the activity level and any of the
variables included in the equation, such as the
hospital or MD in P&RM, prosthetic
components, sex, co-morbidity or reason for
amputation.
Discussion
The aim of this part of the study was to get
insight into the degree of agreement on
prosthetic prescription criteria for lower limb
amputees in the Netherlands. The statistical
results of the observation of clinical practice do
not reveal any consensus between clinicians on
criteria for prosthetic prescription. As to the
second question of this study, there was no clear
relationship between the level of activity and the
prosthetic components within the prescriptions
noted during the observational study. The
criteria used are merely based on clinical
expertise and local experience whereas the
actual prescriptions differ from location to
location. These prescription variations can either
lead to underuse or overuse of prosthetic care in
individual cases.
For none of the prosthetic components
(prosthetic foot, knee mechanism and socket)
was a relationship found with the level of
activity, age of the amputee or time since
amputation. Analysis of location in the
Netherlands or years of experience of the MD in
P&RM did not show any relationship with the
prosthetic prescription. The total population size
in this study was significant for an analysis on
correlations. However, subgroups based on the
level of amputation were too small to allow this
analysis. Causes of amputation differed from
those in the Dutch population as the authors only
observed amputees who were thought to be able
to function with a prosthesis.
During the observation of clinical practice
the functional abilities of individual patients
were mentioned in all individual cases (n=151);
however, they were not explicitly translated
into prosthetic prescription. The decisions seem
to be more influenced by the local experience
with prosthetic components and also based on
the implementation of new products. But there
was some agreement with regard to the
prescriptions for the 3 different amputation
levels. In TT-amputees the total of
prescriptions of a gel-liner for amputees with a
lower activity level was almost equal to that of
the supracondylar-polyform fitting; whereas
for the higher activity level the amount of
prescriptions tended towards the gel-liner (66%
vs. 34%). In literature the authors could not
find any evidence for this subject. As for the
prosthetic foot in TT amputees, a solid-ankle
































176 H. Van der Linde, J. H. B. Geertzen, C. J. Hofstad, J. van Limbeek and K. Postema
of the lower activity amputees and a multi-
flexible foot in 30% of the subjects. For the
higher activity level this was 39% and 30%,
respectively. Hence no explicit agreement has
been found in choosing the prosthetic foot in
TT amputees related to the level of activity.
Gait-analysis studies on this matter offer
additional information. The solid-ankle foot is
described as appropriate for lower-activity-
level amputees, the single-axis foot for
average-activity level and the multiple-axis
foot for moderate-level amputees (Huang et al,
2000). The energy-storing feet are more
appropriate for active walking amputees
(Casillas et al, 1995; Menard et al, 1992).
The motivation for the choice of the prosthetic
foot in KD and TF amputees was widespread.
Several arguments were given, for example its
dependence on the choice of a specific prosthetic
knee. The properties of a prosthetic knee during
gait also depend on the properties of the prosthetic
foot used. Other arguments were stability aspects
during gait, level of activity of the amputee and the
experience with various prosthetic feet. However,
no clear agreement was found. Literature evidence
on this subject is limited. A more symmetrical gait
pattern was seen in TF amputees with a Flex-foot
compared to those using a conventional foot
(MacFarlane et al, 1997).
For the prosthetic socket in KD amputation
there is agreement on the use of a hard socket in
combination with a polyform inner socket as a
first choice and the use of a gel-liner in case of
specific stump problems. There were, however,
no prescriptions of gel-liners observed for KD
amputees. In TF amputees the use of gel-liner
sockets seems a new alternative. In the
prescriptions 22% of the TF sockets contained a
gel-liner, not however for a specific reason like
stump problems or improvement of suspension.
There was a wide range of prosthetic knee-
mechanisms used in the prescriptions, without a
clear overall agreement. Arguments given for
making a choice are most often a measure of
control on knee stability and the intended
walking speed.
From the observational study it can be
concluded that there is some agreement on
several items. Level of activity is an important
factor when prescribing a prosthesis in lower
limb amputees. However, no explicit criteria are
at the prescribers' disposal when matching the
functional ability of the prosthetic user with the
functional properties of prosthetic components
or the complete prosthesis.
There was a wide range of prosthetic
components used for TF, KD and TT amputees
in this study. This could be expected due to a
lack of guidelines for prescription criteria.
Several authors state that the most important
indicator for making choices in the prescription
process is the functional ability of the amputee
(Gailey et al, 2002; Goh et al, 1984; Menard et
al, 1992; Postema et al, 1997). In the authors'
opinion the use of a classification based on these
functional abilities is therefore to be
recommended. In addition, it seems appropriate
to look at aspects of activities of daily life, such
as employment-related factors, to complete the
intended use.
Another cause of the lack of consensus and the
wide range of prosthetic components used can be
found in the level of training and the experience
of the prosthetic team members. The introduction
of a university course for prosthetists could offer
more consistent information for the clinical team
on functional aspects of prosthetic components.
Therefore, the prosthetist ought to have a more
important role in the prescription process than
has been the case up to now. Recently the
upgrading of the prosthetist's educational level
has started in the Netherlands. Secondly, the
continuing education of MD in P&RM is
necessary in order to assure consistency in
knowledge about possible medical problems and
functional abilities of amputees.
It is concluded that there is no consensus in
the Netherlands on prescription criteria for
prosthetic components in lower limb
amputation. However, the agreements found
in this study offer the opportunity for further
development of a consensus-based clinical
guideline on prosthetic prescription. The
development of clinical guidelines is a way of
making prosthetic care more consistent and
efficient and of diminishing the gap between
what clinicans do and what scientific
evidence supports (Woolf et al., 1999).
Guidelines for prosthetic prescription can be
of use now there are more and more options
for prosthetic components. In the Netherlands
third party payers increasingly ask for more
extended motivation for costly prostheses.
For the consumer more transparency is



































The development of a clinical guideline for
prosthetic prescription in the Netherlands in
lower limb amputation is recommended. The use
of a classification of amputees based on mobility
can be a starting point when defining intended
use with an additional status of activities in daily
life and participation such as vocational
interests. The information gained from this
observational study will be combined with the
implicit knowledge given by professional
experts and the scientific evidence from the
available literature. This combined knowledge
will be used in a clinical guideline procedure for
prosthetic prescription in the Netherlands.
Last but not least consumers should take part
in such a process. Lower limb amputee patients
can also take part in developing clinical
guidelines to provide "expert patient opinions"
on care options (Rycroft-Malone, 2001).
Therefore a consumer questionnaire is
recommended as part of a consensus procedure
on prosthetic prescription.
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